ICUCW SEASTAR MEDICAL HOLDING CORP revenue, earnings and financials
For the quarter ended June 30, 2026, SEASTAR MEDICAL HOLDING CORP reported revenue of $615K (up 82.0% from a year earlier), net income of −$3.73M and diluted EPS of n/a; over the last four quarters revenue was $1.71M and net income −$13.6M; for the fiscal year ended December 2025 revenue was $1.23M, up 814.1% on the year before.
ICUCW annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.23M, gross profit $1.18M, operating income −$12.2M, net income −$12.2M (margin -984.6%), EPS n/a
- Fiscal year ended Dec 2024: revenue $135K, gross profit $135K, operating income −$17.8M, net income −$24.8M (margin -18392.6%), EPS −$6.63
- Fiscal year ended Dec 2023: revenue $0, gross profit $0, operating income −$14.2M, net income −$26.2M (margin n/a), EPS −$30.26
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$11.6M, net income −$12.2M (margin n/a), EPS −$1.48
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$4.45M, net income −$4.60M (margin n/a), EPS −$0.63
ICUCW quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $615K (up 82.0% year over year), net income −$3.73M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $495K (up 68.9% year over year), net income −$3.52M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $420K (up 526.9% year over year), net income −$2.90M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $183K (up 169.1% year over year), net income −$3.47M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $338K, net income −$2.00M, EPS −$0.18
- Quarter ended Mar 31, 2025: revenue $293K, net income −$3.77M, EPS −$0.44
- Quarter ended Dec 31, 2024 (from the annual report): revenue $67.0K, net income −$4.42M, EPS $0.23
- Quarter ended Sep 30, 2024: revenue $68.0K, net income −$4.48M, EPS −$1.10
- Quarter ended Jun 30, 2024: revenue $0, net income −$3.24M, EPS −$1.03
- Quarter ended Mar 31, 2024: revenue $0, net income −$12.7M, EPS −$4.73
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$9.46M, EPS −$16.60
- Quarter ended Sep 30, 2023: revenue $0, net income −$7.23M, EPS −$9.02
- Quarter ended Jun 30, 2023: revenue n/a, net income −$2.45M, EPS −$4.10
- Quarter ended Mar 31, 2023: revenue n/a, net income −$7.10M, EPS −$0.54
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$8.39M, EPS −$0.96
- Quarter ended Sep 30, 2022: revenue n/a, net income −$1.89M, EPS −$0.26
- Quarter ended Jun 30, 2022: revenue n/a, net income −$902K, EPS −$0.12
- Quarter ended Mar 31, 2022: revenue n/a, net income −$1.00M, EPS −$0.14
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$4.56M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income $236K, EPS n/a
ICUCW cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$13.6M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$16.0M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$10.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$7.79M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$5.11M, share buybacks n/a
ICUCW balance sheet
- Jun 30, 2026: cash n/a, total assets $8.65M, total liabilities $4.35M, shareholders' equity $4.30M
- Mar 31, 2026: cash n/a, total assets $11.3M, total liabilities $3.95M, shareholders' equity $7.32M
- Dec 31, 2025: cash n/a, total assets $14.2M, total liabilities $3.74M, shareholders' equity $10.4M
- Sep 30, 2025: cash n/a, total assets $15.5M, total liabilities $4.07M, shareholders' equity $11.5M
- Jun 30, 2025: cash n/a, total assets $8.38M, total liabilities $5.04M, shareholders' equity $3.34M
- Mar 31, 2025: cash n/a, total assets $14.2M, total liabilities $7.03M, shareholders' equity $565K
- Dec 31, 2024: cash n/a, total assets $4.66M, total liabilities $6.84M, shareholders' equity −$2.18M
- Sep 30, 2024: cash n/a, total assets $4.59M, total liabilities $6.64M, shareholders' equity −$2.05K
What is ICUCW's revenue?
SEASTAR MEDICAL HOLDING CORP reported $1.71M of revenue over its last four quarters, through June 30, 2026.
Is ICUCW profitable?
No. SEASTAR MEDICAL HOLDING CORP lost $13.6M over the last four quarters.